
Inogen INGN
$ 6.27
-1.1%
Annual report 2025
added 02-27-2026
Inogen Total Current Liabilities 2011-2026 | INGN
Annual Total Current Liabilities Inogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.5 M | 76.7 M | 72.5 M | 65.3 M | 61.5 M | 56.7 M | 50.2 M | 46.6 M | 33.9 M | 22.8 M | 22 M | 18.7 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 76.7 M | 18.7 M | 49.2 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
2.04 B | $ 186.03 | 0.73 % | $ 13.9 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | ||
|
AdaptHealth Corp.
AHCO
|
712 M | $ 12.63 | -1.14 % | $ 1.71 B | ||
|
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | ||
|
BioSig Technologies
BSGM
|
42.8 M | - | 37.08 % | $ 85.7 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
468 M | $ 296.18 | 1.28 % | $ 8.36 B | ||
|
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
37.8 M | $ 3.41 | 1.14 % | $ 128 M | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 39.74 | -0.4 % | $ 5.92 K | ||
|
Boston Scientific Corporation
BSX
|
5.44 B | $ 64.35 | 0.84 % | $ 95.3 B | ||
|
Cytosorbents Corporation
CTSO
|
9.71 M | $ 0.6 | 1.14 % | $ 37.3 M | ||
|
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
1.88 M | $ 1.95 | -1.77 % | $ 1.19 M | ||
|
ClearPoint Neuro
CLPT
|
10.8 M | $ 10.51 | 1.25 % | $ 298 M | ||
|
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
6.6 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
10.5 M | $ 25.59 | 1.51 % | $ 216 M | ||
|
IRIDEX Corporation
IRIX
|
13.2 M | $ 1.02 | -0.71 % | $ 17.3 M | ||
|
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | ||
|
LENSAR
LNSR
|
40.6 M | $ 6.22 | 2.97 % | $ 74.4 M | ||
|
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | ||
|
Globus Medical
GMED
|
498 M | $ 94.7 | -0.24 % | $ 12.8 B | ||
|
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 17.96 | 0.56 % | $ 421 M | ||
|
Butterfly Network
BFLY
|
48.2 M | $ 4.8 | 8.47 % | $ 1.02 B | ||
|
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | ||
|
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | ||
|
Myomo
MYO
|
8.35 M | $ 0.8 | 2.29 % | $ 33.5 M | ||
|
Delcath Systems
DCTH
|
11 M | $ 10.98 | 0.92 % | $ 393 M | ||
|
Inspire Medical Systems
INSP
|
96.1 M | $ 57.39 | 0.93 % | $ 1.69 B | ||
|
CONMED Corporation
CNMD
|
315 M | $ 39.24 | -1.23 % | $ 1.22 B | ||
|
LivaNova PLC
LIVN
|
808 M | $ 64.84 | -0.23 % | $ 3.54 B | ||
|
Integer Holdings Corporation
ITGR
|
232 M | $ 87.21 | -1.59 % | $ 3.03 B | ||
|
FONAR Corporation
FONR
|
16.7 M | $ 18.75 | -0.05 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.81 B | $ 77.86 | -0.43 % | $ 45.5 B | ||
|
NanoVibronix
NAOV
|
2.72 M | - | - | $ 1.08 M |